US panel says to loosen restrictions on popular peptide despite safety concerns
NEW YORK - A US review panel on Thursday recommended loosening restrictions on the much hyped peptide BPC-157, voting that specialized pharmacies be allowed to produce it despite alarm bells from medical experts over safety concerns.
Bangkok Post ·